Evidence map›Paper›PMID 32572676›Full record

ArticleJournal of thrombosis and thrombolysis2020

Correction to: Heparin resistance in COVID‑19 patients in the intensive care unit.

D White, S MacDonald, T Bull, M Hayman, D de Monteverde-Robb, D Sapsford, A Lavinio, J Varley, A Johnston, M Besser and 1 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of thrombosis and thrombolysis, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors.

D WhiteDepartment of Haematology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
S MacDonaldDepartment of Haematology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
T BullDepartment of Haematology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
M HaymanDepartment of Haematology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
D de Monteverde-RobbPharmacy Department, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
D SapsfordPharmacy Department, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
A LavinioDepartment of Intensive Care Medicine, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
J VarleyDepartment of Intensive Care Medicine, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
A JohnstonDepartment of Intensive Care Medicine, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
M BesserDepartment of Haematology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
W ThomasDepartment of Haematology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK. william.thomas@addenbrookes.nhs.uk.ORCID 0000-0001-6969-3173

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In the original publication of this article, one of the co-author name "D. de Monteverde-Robb" was inadvertently mentioned as "R. de Monteverde-Robb". The correct author name is "D. de Monteverde-Robb". This error has been corrected with this erratum.

Identifiers

PMID32572676
PMCPMC7306566

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.